Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who present to Wake Forest Baptist Medical Center for a direct current cardioversion for treatment of paroxysmal or persistent atrial fibrillation as well as atrial flutter.~Exclusion Criteria:~* Patients with sedation for transesophageal echocardiogram within 30 minutes of DCCV~* Hemodynamically compromised patients (as defined by hypotension \<90/50 mmHg, altered mental status, shock, ischemic chest discomfort, or heart failure)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sedation with propofol group (Type: EXPERIMENTAL): Participants in this group will be randomized to sedation with bolus dosing of propofol for cardioversion.
- Sedation with methohexital group (Type: EXPERIMENTAL): Participants in this group will be randomized to sedation with bolus dosing of methohexital for cardioversion.

Based on this trial design, predict the completion outcome and termination type (if applicable).